本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eikon Therapeutics

8.94
-0.2700-2.93%
盤後8.940.00000.00%19:30 EDT
成交量:101.02萬
成交額:907.69萬
市值:4.83億
市盈率:-1.50
高:9.56
開:9.28
低:8.79
收:9.21
52周最高:17.40
52周最低:7.90
股本:5,398.43萬
流通股本:1,764.80萬
量比:2.02
換手率:5.72%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-115.2900
淨資產收益率:-125.02%
總資產收益率:-36.19%
市淨率:1.03
市盈率(LYR):-0.08

資料載入中...

2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/28

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933